APOTEX CORP — Atorvastatin Importer Profile
Pharmaceutical Importer · #1 buyer for Atorvastatin · $24.4M import value · 566 shipments · UNITED STATES · DGFT Verified
APOTEX CORP is the #1 importer of Atorvastatin from India with $24.4M in import value and 566 verified shipments. APOTEX CORP holds a 2.0% market share in Atorvastatin imports based in UNITED STATES. The company sources from 2 verified suppliers across 334 formulations shipped to 1 country. Overall, APOTEX CORP imports 4 pharmaceutical products worth $37.3M across 4 therapeutic categories.
APOTEX CORP — Atorvastatin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Atorvastatin to APOTEX CORP?
Verified from 566 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| PIRAMAL PHARMA LIMITED | $21.0M | 485 | 86.0% |
| APOTEX RESEARCH PRIVATE LIMITED | $3.4M | 81 | 14.0% |
APOTEX CORP sources Atorvastatin from 2 verified Indian suppliers based on 566 customs records. The primary supplier is PIRAMAL PHARMA LIMITED accounting for 86.0% of imports.
How Does APOTEX CORP Compare to Nearest Atorvastatin Importers?
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | APL SWIFT SERVICES (MALTA) LTD., | MALTA | $25.9M | 517 | $50.0K |
| 1 | APOTEX CORP ★ | UNITED STATES | $21.4M | 429 | $50.0K |
| 8 | NOVADOZ PHARMACEUTICALS LLC | UNITED STATES | $17.3M | 549 | $31.4K |
| 9 | BIOCON PHARMA INC | UNITED STATES | $16.0M | 339 | $47.3K |
APOTEX CORP ranks #1 among 1,291 Atorvastatin importers from India. Average shipment value of $50.0K compared to the market average of $117.9K. The closest competitors by value are APL SWIFT SERVICES (MALTA) LTD., and NOVADOZ PHARMACEUTICALS LLC.
Where Does APOTEX CORP Import Atorvastatin To?
Destination countries from 566 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $24.4M | 566 | 100.0% |
APOTEX CORP imports Atorvastatin to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $24.4M.
What Atorvastatin Formulations Does APOTEX CORP Import?
| Formulation | Value | Shipments |
|---|---|---|
| (401291027) ATORVASTATIN CALCIUM TABLETS | $1.2M | 26 |
| (401291022) ATORVASTATIN FCT 20MG 90 BTL | $780.8K | 16 |
| (401291020) ATORVASTATIN FCT 10MG 90 BTL | $500.0K | 10 |
| (401291024) Atorvastatin Calcium Tablets | $483.6K | 10 |
| 401291027 ATORVASTATIN CALCIUM TABLETS | $477.0K | 10 |
| (401291024)Atorvastatin Calcium Tablets | $450.0K | 9 |
| 401291025 ATORVASTATIN FCT 40MG 1000 B | $450.0K | 9 |
| (401291021) ATORVASTATIN CALCIUM TABLETS | $400.0K | 8 |
| 401291026 Atorvastatin Calcium Tabs 80 | $376.4K | 8 |
| (401291023) ATORVASTATIN FCT 20MG 1000 B | $344.0K | 8 |
APOTEX CORP imports 334 distinct Atorvastatin formulations from India. The top formulation is (401291027) ATORVASTATIN CALCIUM TABLETS with 26 shipments worth $1.2M.
Regulatory Requirements: Importing Atorvastatin into United States
What APOTEX CORP and other importers must comply with to import Atorvastatin from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Atorvastatin
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Atorvastatin from India and How Much Does APOTEX CORP Import?
India exported $152.2M worth of Atorvastatin through 15,000 shipments from 477 suppliers to 145 countries, serving 1,291 buyers globally. APOTEX CORP imports $24.4M of this total, accounting for 2.0% of India's Atorvastatin exports with 566 shipments from UNITED STATES. This is verified from 566 customs shipment records covering 334 distinct formulations.
What Is the Average Order Value for APOTEX CORP's Atorvastatin Imports?
APOTEX CORP's average Atorvastatin order value is $43.2K per consignment, based on 566 shipments totaling $24.4M. APOTEX CORP is based in UNITED STATES and ranks #1 among all Atorvastatin importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Atorvastatin to APOTEX CORP?
APOTEX CORP sources Atorvastatin from 2 verified Indian suppliers: PIRAMAL PHARMA LIMITED ($21.0M, 86.0%), APOTEX RESEARCH PRIVATE LIMITED ($3.4M, 14.0%). This is based on 566 customs records.
How Does APOTEX CORP Compare to Other Atorvastatin Importers?
APOTEX CORP ranks #1 among 1,291 Atorvastatin importers from India with a 2.0% market share. The top 3 importers are APL SWIFT SERVICES (MALTA) LTD., ($25.9M), APOTEX CORP ($21.4M), NOVADOZ PHARMACEUTICALS LLC ($17.3M). APOTEX CORP processed 566 shipments from UNITED STATES.
About APOTEX CORP
APOTEX CORP imports 4 products worth $37.3M. Beyond Atorvastatin, top products include Calcium, Paclitaxel, Protein. View the complete APOTEX CORP profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Atorvastatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Atorvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: APOTEX CORP matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as APOTEX CORP's capped import value divided by total capped export value for Atorvastatin across all Indian exporters.
- 5.Verified Records: This page is backed by 566 individual customs records matching APOTEX CORP importing Atorvastatin, covering 334 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 145+ countries, 1,291+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Atorvastatin Import Data for APOTEX CORP
Access order-level details, pricing data, supplier connections, and competitive analysis for APOTEX CORP's Atorvastatin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
APOTEX CORP
Full Company Profile →
4 products · $37.3M total trade · 4 categories
APOTEX CORP × Atorvastatin
Verified from customs records
Company Overview
Top Products by APOTEX CORP
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for APOTEX CORP.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Atorvastatin. For current order-level data, contact TransData Nexus.